Replies to post #125993 on Innovation Pharmaceuticals Inc (IPIX)

[Whoops]

Nice post NR. I think and in some ways sadly our next catalyst driving us back up to $2 might be finding out what are big law firm is going to do to Rosen and hopefully Mako.

[Phoenix300]

Nice post NR. Frankly I would just like to learn that the trial has ended. Then open the doors and see what's behind door number 2.

[Phoenix300]

Over a month since we were made aware of the final 3 patients being recruited.

BEVERLY, MA–(Marketwired – September 08, 2015) – Cellceutix Corporation (OTC: CTIX) (the “Company”), a clinical stage biopharmaceutical company developing innovative therapies with oncology, dermatology, anti-inflammatory and antibiotic applications, is pleased to announce that it will be concluding its Phase 1 trial of the novel compound Kevetrin in patients with advanced solid tumors at the completion of the current cohort. The final cohort requires that six patients be treated at the maximum tolerated dose. Three of the six patients in the cohort have already completed the required treatments with Kevetrin. Cellceutix has been advised that the remaining three patients are currently being recruited.

.....

- See more at: http://cellceutix.com/cellceutix-plans-for-phase-2-clinical-trial-in-ovarian-cancer/#sthash.2z1isJCq.dpuf